Por favor, use este identificador para citar o enlazar este ítem: https://hdl.handle.net/11000/31281
Registro completo de metadatos
Campo DC Valor Lengua/Idioma
dc.contributor.authorde Miguel Balsa, Eva-
dc.contributor.authorLatour-Perez, Jaime-
dc.contributor.authorBaeza Roman, Anna-
dc.contributor.authorLlamas-Álvarez, Ana-
dc.contributor.authorRuiz-Ruiz, Javier-
dc.contributor.authorFuset-Cabanes, María Paz-
dc.contributor.authorARIAM-SEMICYUC group-
dc.contributor.otherDepartamentos de la UMH::Medicina Clínicaes_ES
dc.date.accessioned2024-02-08T11:36:55Z-
dc.date.available2024-02-08T11:36:55Z-
dc.date.created2015-
dc.identifier.citationJournal of Women's Health (Larchmt) . 2015 Nov;24(11):882-8es_ES
dc.identifier.issn1931-843X-
dc.identifier.urihttps://hdl.handle.net/11000/31281-
dc.description.abstractBackground: The available evidence about the effect of gender and/or sex on mortality differences is contradictory. Our aim is to assess the impact of gender on the access to reperfusion therapy in patients with acute coronary syndrome with ST-segment elevation (STEMI), and secondly, to analyze the effect of delay on the differences with regard to hospital mortality. Methods: A retrospective cohort study was conducted among consecutive patients with STEMI included in the ARIAM-SEMICYUC registry (2010-2013).Results: A total of 4816 patients were included (22.09% women). Women were older, presented with longer patient delay (90 vs. 75 minutes, p=0.0066), higher risk profile (GRACE>140: 75.1% vs. 56.05%, p<0.0001), and received less reperfusion therapy (68.8% vs. 74.7%, p<0.0001) with longer total reperfusion time (307 vs. 240 minutes, p<0.0001). Women received less thrombolysis (24.53% vs. 29.98%, p<0.0001) and longer door-to-needle time (85 vs. 70 minutes, p 0.0023). We found no differences regarding primary percutaneous coronary intervention or door-to-balloon time. Women also had higher hospital mortality (crude odds ratio 2.54, 95% confidence interval 1.99-3.26, p<0.0001), which persisted after controlling the effect of patient delay, age, risk (GRACE), and reperfusion (adjusted odds ratio 1.43, 95% confidence interval 1.0-2.06, p=0.0492). Using TIMI or Killip risk scores as risk estimates yielded nonsignificant results.Conclusions: Compared with men, women with STEMI have worse access to reperfusion and higher hospital mortality. The impact of the differences in accessibility on mortality gap remains uncertain.es_ES
dc.formatapplication/pdfes_ES
dc.format.extent7es_ES
dc.language.isoenges_ES
dc.publisherMary Ann Liebertes_ES
dc.rightsinfo:eu-repo/semantics/closedAccesses_ES
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 Internacional*
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/*
dc.titleAccessibility to Reperfusion Therapy Among Women with Acute Myocardial Infarction: Impact on Hospital Mortalityes_ES
dc.typeinfo:eu-repo/semantics/articlees_ES
dc.relation.publisherversionhttps://doi.org/10.1089/jwh.2014.5011es_ES
Aparece en las colecciones:
Artículos Medicina Clínica


no-thumbnailVer/Abrir:

 Accessibility to Reperfusion Therapy Among.pdf



141,57 kB
Adobe PDF
Compartir:


Creative Commons La licencia se describe como: Atribución-NonComercial-NoDerivada 4.0 Internacional.